Profile | GDS5420 / 234387_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 50.15 | 31 |
GSM1296119 | B_lesional_pre-dose | 73.32 | 35 |
GSM1296076 | C_lesional_pre-dose | 67.56 | 36 |
GSM1296092 | D_lesional_pre-dose | 88.79 | 42 |
GSM1296103 | E_lesional_pre-dose | 53.89 | 33 |
GSM1296078 | F_lesional_pre-dose | 79.93 | 39 |
GSM1296107 | G_lesional_pre-dose | 65.6 | 33 |
GSM1296109 | H_lesional_pre-dose | 49.94 | 29 |
GSM1296080 | I_lesional_pre-dose | 88.87 | 41 |
GSM1296090 | J_lesional_pre-dose | 95.85 | 42 |
GSM1296074 | K_lesional_pre-dose | 99.87 | 44 |
GSM1296111 | L_lesional_pre-dose | 105.27 | 40 |
GSM1296099 | M_lesional_pre-dose | 78.21 | 38 |
GSM1296086 | O_lesional_pre-dose | 96.15 | 42 |
GSM1296117 | P_lesional_pre-dose | 135.37 | 44 |
GSM1296113 | Q_lesional_pre-dose | 118.82 | 41 |
GSM1296096 | R_lesional_pre-dose | 61.48 | 35 |
GSM1296105 | S_lesional_pre-dose | 56.38 | 32 |
GSM1296098 | T_lesional_pre-dose | 126.63 | 44 |
GSM1296101 | U_lesional_pre-dose | 37.55 | 27 |
GSM1296121 | V_lesional_pre-dose | 67.75 | 34 |
GSM1296088 | W_lesional_pre-dose | 82.15 | 39 |
GSM1296082 | X_lesional_pre-dose | 86.49 | 41 |
GSM1296115 | Y_lesional_pre-dose | 113.42 | 42 |
GSM1296084 | Z_lesional_pre-dose | 87.61 | 39 |
GSM1296072 | B_lesional_day8 | 72.13 | 35 |
GSM1296069 | L_lesional_day8 | 103.13 | 39 |
GSM1296071 | P_lesional_day8 | 130.95 | 43 |
GSM1296070 | Y_lesional_day8 | 101.45 | 39 |
GSM1296073 | V_lesional_day8 | 32.2 | 23 |
GSM1296034 | A_lesional_day15 | 100.43 | 40 |
GSM1296041 | G_lesional_day15 | 99.34 | 40 |
GSM1296035 | R_lesional_day15 | 46.79 | 32 |
GSM1296038 | U_lesional_day15 | 105.51 | 42 |
GSM1296047 | B_lesional_day15 | 88.56 | 37 |
GSM1296039 | E_lesional_day15 | 101.32 | 42 |
GSM1296042 | H_lesional_day15 | 83.96 | 36 |
GSM1296043 | L_lesional_day15 | 121.73 | 42 |
GSM1296037 | M_lesional_day15 | 81.74 | 37 |
GSM1296046 | P_lesional_day15 | 137.86 | 44 |
GSM1296044 | Q_lesional_day15 | 152.95 | 46 |
GSM1296045 | Y_lesional_day15 | 94.08 | 37 |
GSM1296025 | C_lesional_day15 | 99.36 | 42 |
GSM1296033 | D_lesional_day15 | 124.51 | 45 |
GSM1296027 | I_lesional_day15 | 140.75 | 49 |
GSM1296032 | J_lesional_day15 | 100.22 | 41 |
GSM1296024 | K_lesional_day15 | 126.72 | 46 |
GSM1296031 | W_lesional_day15 | 115.59 | 43 |
GSM1296028 | X_lesional_day15 | 127.5 | 46 |
GSM1296029 | Z_lesional_day15 | 115.75 | 44 |
GSM1296026 | F_lesional_day15 | 62.67 | 34 |
GSM1296030 | O_lesional_day15 | 86.49 | 42 |
GSM1296040 | S_lesional_day15 | 104.64 | 41 |
GSM1296036 | T_lesional_day15 | 100.44 | 40 |
GSM1296048 | V_lesional_day15 | 45.01 | 27 |
GSM1296059 | A_lesional_day43 | 42.55 | 30 |
GSM1296066 | G_lesional_day43 | 106.45 | 40 |
GSM1296060 | R_lesional_day43 | 41.19 | 29 |
GSM1296063 | U_lesional_day43 | 59.05 | 33 |
GSM1296064 | E_lesional_day43 | 66.77 | 36 |
GSM1296067 | H_lesional_day43 | 78.46 | 35 |
GSM1296062 | M_lesional_day43 | 55.77 | 33 |
GSM1296068 | Q_lesional_day43 | 122.58 | 41 |
GSM1296050 | C_lesional_day43 | 108.78 | 42 |
GSM1296057 | D_lesional_day43 | 56.67 | 34 |
GSM1296052 | I_lesional_day43 | 112.37 | 45 |
GSM1296054 | J_lesional_day43 | 163.84 | 48 |
GSM1296049 | K_lesional_day43 | 112.45 | 43 |
GSM1296055 | W_lesional_day43 | 70.46 | 35 |
GSM1296053 | X_lesional_day43 | 122.73 | 45 |
GSM1296058 | Z_lesional_day43 | 28.98 | 25 |
GSM1296051 | F_lesional_day43 | 71.37 | 37 |
GSM1296056 | O_lesional_day43 | 30.21 | 25 |
GSM1296065 | S_lesional_day43 | 114.08 | 43 |
GSM1296061 | T_lesional_day43 | 71 | 35 |
GSM1296095 | A_non-lesional_pre-dose | 134.47 | 47 |
GSM1296120 | B_non-lesional_pre-dose | 115.11 | 42 |
GSM1296077 | C_non-lesional_pre-dose | 83.01 | 39 |
GSM1296093 | D_non-lesional_pre-dose | 110.68 | 42 |
GSM1296104 | E_non-lesional_pre-dose | 62.75 | 34 |
GSM1296079 | F_non-lesional_pre-dose | 95.72 | 41 |
GSM1296108 | G_non-lesional_pre-dose | 131.64 | 44 |
GSM1296110 | H_non-lesional_pre-dose | 130.11 | 43 |
GSM1296081 | I_non-lesional_pre-dose | 65.22 | 37 |
GSM1296091 | J_non-lesional_pre-dose | 154.27 | 49 |
GSM1296075 | K_non-lesional_pre-dose | 127.93 | 47 |
GSM1296112 | L_non-lesional_pre-dose | 138.32 | 43 |
GSM1296100 | M_non-lesional_pre-dose | 62.4 | 34 |
GSM1296087 | O_non-lesional_pre-dose | 59.49 | 36 |
GSM1296118 | P_non-lesional_pre-dose | 147.34 | 45 |
GSM1296114 | Q_non-lesional_pre-dose | 175.43 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 101.3 | 41 |
GSM1296106 | S_non-lesional_pre-dose | 115.38 | 42 |
GSM1296102 | U_non-lesional_pre-dose | 64.01 | 34 |
GSM1296122 | V_non-lesional_pre-dose | 67.13 | 33 |
GSM1296089 | W_non-lesional_pre-dose | 150.57 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 65.77 | 35 |
GSM1296116 | Y_non-lesional_pre-dose | 158.74 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 116.17 | 44 |